Luo, Jun <br/><br/>
Targeting survival pathways to create infarct-spanning bridges of human embryonic stem cell-derived cardiomyocytes.  [electronic resource] 

 -  The Journal of thoracic and cardiovascular surgery  Dec 2014 
 - 3180-8.e1 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Video-Audio Media 
<br/><br/><label>ISSN: </label>1097-685X 
<br/><br/><label>Standard No.: </label>10.1016/j.jtcvs.2014.06.087  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Cell Differentiation<br/>Cell Line<br/>Cell Proliferation--drug effects<br/>Cell Survival--drug effects<br/>Cytoprotection<br/>Disease Models, Animal<br/>Embryonic Stem Cells--drug effects<br/>Graft Survival--drug effects<br/>Heme Oxygenase (Decyclizing)--metabolism<br/>Humans<br/>Molecular Targeted Therapy<br/>Myocardial Contraction--drug effects<br/>Myocardial Infarction--metabolism<br/>Myocardium--metabolism<br/>Myocytes, Cardiac--drug effects<br/>Protoporphyrins--pharmacology<br/>Rats, Nude<br/>Signal Transduction--drug effects<br/>Time Factors<br/>Up-Regulation<br/>Ventricular Function--drug effects